ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Ra Medical’s Electrophysiology Division Announces First Hospital to Complete 100 Procedures Using the VIVO System

FORT MILL, SC / ACCESSWIRE / June 12, 2023 / Ra Medical Systems, Inc. (RMED:NYSE/American) announced today that its wholly owned subsidiary, Catheter Precision, Inc., has had its first customer, Heart Hospital of New Mexico at Lovelace Medical Center, complete 100 ventricular ablation procedures with the assistance of VIVO, a non-invasive 3D imaging system that identifies the earliest electrical activation of a ventricular arrhythmia.

"This is a significant milestone for Catheter Precision", said David Jenkins, interim CEO. "We continue to believe that physicians and hospitals will find value using VIVO and to see a hospital use it this much in a relatively short period of time demonstrates that the benefits of VIVO are being recognized and that our utilization strategies are working."

VIVO is used to assist physicians in physicians in pre-procedure planning for ventricular ablations. When used in advance of the procedure, VIVO can provide additional information to the physician about the patient's heart to streamline what are often long and complicated procedures lasting 4-5 hours.

Dr Sean Mazer, MD, clinical Electrophysiologist at the Heart Hospital of New Mexico and president of the New Mexico Heart Institute/Lovelace Medical Group says, "We have implemented VIVO in all of our PVC ablations. It has helped speed up and improve the workflow for our most difficult procedures. It has also improved the chances of successful ablation for the patients. Some of these arrhythmias were not treatable without VIVO."

Catheter Precision recently built out a direct sales team in early 2023 to expand upon the successful, but limited launch and to expand its footprint across the United States.

About VIVO

Catheter Precision's VIVO™ (View Into Ventricular Onset), is a non-invasive 3D imaging system that enables physicians to identify the origin of ventricular arrhythmias pre-procedure, thereby streamlining workflow and reducing procedure time. VIVO has received marketing clearance from the U.S. FDA and has the CE mark.

About Ra Medical Systems

Ra Medical, and its wholly owned subsidiary Catheter Precision, is an innovative U.S.-based medical device company bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is focused on developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products.

CONTACTS:

At the Company
David Jenkins
973-691-2000
mhuck@catheterprecision.com

SOURCE: Ra Medical Systems



View source version on accesswire.com:
https://www.accesswire.com/760298/Ra-Medicals-Electrophysiology-Division-Announces-First-Hospital-to-Complete-100-Procedures-Using-the-VIVO-System

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.